chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I felt kind of cold; had a little bit of fever; This is a spontaneous report from a contactable consumer. A 68-year-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK5730, expiration date not reported), via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The consumer stated, she works at university hospital and she got the Covid 19 shot. The side effect, she felt kind of cold and had a little bit of fever, on an unspecified date. The consumer stated, 'I am warm now. When I was at work there, I was in a room and it just got cold to me.' She stated that she is supposed to take the next shot, the date 23Dec2020. Outcome of the events was unknown.
her two lymph nodes were swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), on 08Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, Unknown Manufacturer, Primary immunization completed), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2, Unknown Manufacturer, Primary immunization completed), for COVID-19 Immunization; Covid-19 vaccine (DOSE 3 (Booster), Unknown Manufacturer, Primary immunization completed), for COVID-19 Immunization.  The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "her two lymph nodes were swollen".  Additional Information: Caller was a consumer. She stated she received her second booster of the COMIRNATY vaccine on 08Apr2022. The next day her two lymph nodes were swollen. She was told this was a common side effect, but this lymph nodes were still swollen. She mentioned the swollen lymph nodes were located in her neck. She asked if this was common since it had been 3 weeks since she got the second booster dose.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
p/vax pt devel golf ball sized lymph node under rt arm;went to ER;did lab tests better w/in 3 days;
Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B214 and 001A21A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable
Per pt, "developed cellulitis of the right deltoid area; 2 days, post vax. Was placed on 2 antibiotics (Keflex and Biaxin) and Prednisone, per pt.
started day p/ 2OCT97, crying no fever, piercing cry, some congestion, then vomiting started;
Stiffness /Pain on left side of head from temple down to neck & shoulder.  Painful to turn head to left. Sharp pain in temper/ear area down back of head.  Painful at times to hold head up. Dull Headache.  TREATMENT: 3/18/21 - Primary Care Physician administer Ibuprofen shot to right side of shoulder, Prescribed Muscle Relaxer, referred for X-Ray of Shoulder.  3/30/2021 - Primary Care Physician re-examined - Prescribed Antibiotics for 14 days - referred for CT Scan of Sinus area.   4/6/2021 - Primary Care Physician re-examined referred for CT Scan of Brain/Head.  4/13 - Primary Care Physician re-Examined - prescribed  Methylprednis-Olone for 6 days and referral to Neurology. .
got sick; This is a spontaneous report from a contactable Consumer or other non-health care professional (Parent) reported for her daughter. A 43-years-old female bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; batch no/Lot number: not reported) via unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization and also received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; batch no/Lot number: not reported) via unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. Patient medical history and concomitant medications were not reported. It was reported that patient had both doses and got severely hurt by Pfizer vaccine after first dose, and also stated fortunately she doesn't have long term effects. Caller stated she will not get the third shot definitely. She had the first one and had an adverse reaction that was when she really got sick, and she was warned but didn't pay attention to parent. She did not think it was severe enough to not get the second dose. Outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
G47.33 OBSTRUCTIVE SLEEP APNEA 2/7/2022 HX OF FALL I24.8 DEMAND ISCHEMIA 7/12/2021 HX OF FALL J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/3/2022 HX OF FALL J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/21/2021 HX OF FALL J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/23/2021 HX OF FALL R29.810 RIGHT FACIAL MUSCLE WEAKNESS 2/17/2022 HX OF FALL G47.33 OBSTRUCTIVE SLEEP APNEA 2/7/2022 ULCER OF LEFT FOOT, UNSPECIFIED DEPTH I24.8 DEMAND ISCHEMIA 7/12/2021 ULCER OF LEFT FOOT, UNSPECIFIED DEPTH J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/3/2022 ULCER OF LEFT FOOT, UNSPECIFIED DEPTH J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/21/2021 ULCER OF LEFT FOOT, UNSPECIFIED DEPTH J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/23/2021 ULCER OF LEFT FOOT, UNSPECIFIED DEPTH R29.810 RIGHT FACIAL MUSCLE WEAKNESS 2/17/2022 ULCER OF LEFT FOOT, UNSPECIFIED DEPTH G47.33 OBSTRUCTIVE SLEEP APNEA 2/7/2022 ULCER OF LEFT LOWER LEG, UNSPECIFIED SITE AND DEPTH I24.8 DEMAND ISCHEMIA 7/12/2021 ULCER OF LEFT LOWER LEG, UNSPECIFIED SITE AND DEPTH J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/3/2022 ULCER OF LEFT LOWER LEG, UNSPECIFIED SITE AND DEPTH J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/21/2021 ULCER OF LEFT LOWER LEG, UNSPECIFIED SITE AND DEPTH J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/23/2021 ULCER OF LEFT LOWER LEG, UNSPECIFIED SITE AND DEPTH R29.810 RIGHT FACIAL MUSCLE WEAKNESS 2/17/2022 ULCER OF LEFT LOWER LEG, UNSPECIFIED SITE AND DEPTH G47.33 OBSTRUCTIVE SLEEP APNEA 2/7/2022 OSTEOMYELITIS I24.8 DEMAND ISCHEMIA 7/12/2021 OSTEOMYELITIS J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/3/2022 OSTEOMYELITIS J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/21/2021 OSTEOMYELITIS J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/23/2021 OSTEOMYELITIS R29.810 RIGHT FACIAL MUSCLE WEAKNESS 2/17/2022 OSTEOMYELITIS G47.33 OBSTRUCTIVE SLEEP APNEA 2/7/2022 BACTEREMIA I24.8 DEMAND ISCHEMIA 7/12/2021 BACTEREMIA J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/3/2022 BACTEREMIA J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/21/2021 BACTEREMIA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 6/23/2021 BACTEREMIA R29.810 RIGHT FACIAL MUSCLE WEAKNESS 2/17/2022 BACTEREMIA
Immediately post vax, the pt broke out in red blotchy rash on forehead and shoulders. No respiratory distress. Pt medicated with Benadryl and rash faded within 10 minutes.
1st dose on 2020, did not receive 2nd dose due to COVID pandemic; This case was reported by a consumer via call center representative and described the occurrence of social problem in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles on 28th July 2020) and pruritus (had itching from the inside). Previously administered products included Flu vaccine (received flu vaccine on 22nd September 2020), Zostavax (received the original Shingles vaccine years ago) and Shingrix (recived 1st dose on 22nd September 2020, in an unknown arm).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. The patient did not receive 2nd dose of Shingrix due to COVID pandemic, which led to social problem.  The patient received the original Shingles vaccine years ago (Zostavax). The patient came down with the Shingles disease on 28th July 2020. The patient did not have a rash or blisters, but  he itched from the inside. The patient received Shingrix 1st dose and flu vaccine at the same time on an unknown arm. The reporter consented to follow up.
developed an allergy or sensitivity to glycols since receiving the covid vaccine; This has resulted in not being able to color my hair, take meds, wear makeup, eat most foods.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:  The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "developed an allergy or sensitivity to glycols since receiving the covid vaccine"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "unknown", described as "This has resulted in not being able to color my hair, take meds, wear makeup, eat most foods.".  Additional Information: It was reported that; it appears that patient had developed an allergy or sensitivity to glycols since receiving the covid vaccine. This has resulted in not being able to color patient hair, take meds, wear makeup, eat most foods. Further, it was asked Pfizer developing a drug to reverse the effects of what peg did to a number of people who got the vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sharp pain at the injection site; This is spontaneous report from a contactable consumer. A 61-year-old male consumer (patient) reported for himself that he received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number: EW0172) via unspecified route of administration in left arm on 06May2021 13:30 (age at vaccination was 61 years) as 2nd dose single dose for COVID-19 immunization. The patient's medical history included blood pressure, cholesterol and allergic to dogs, cats, horses, ragweed from unspecified dates. The patient's concomitant medication includes hydrochlorothiazide 25mg, amlodipine besilate 10mg, lisinopril 40mg for blood pressure, rosuvastatin 10mg for cholesterol on unspecified dates. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number: EW0150) dose 1 via unspecified route of administration in left arm on 14Apr2021 13:30 as 1 dose single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On unspecified date, it was reported that, the patient had the first dose of the Pfizer Covid Vaccine on 14Apr2021 and had the second dose on 06May2021, more than 21 days later. After the first dose he had a sore arm, and after the second dose he still has sharp pain at the injection site a month later. Patient comes on the line. He had the first shot and had no reaction whatsoever, not even any pain in his arm until a week and a half or 2 weeks later and it was minor pain. After the second shot he had no allergic reaction and no problems. He got the second dose on 06May2021. Within the last 2 weeks or so every time he moves his arm a certain way, he has a sharp pain in the injection site. Normally there is some soreness that goes away, he is surprised to still have this. He didn't call his doctor because it is too new and they won't know. Second dose sharp pain in the injection site, After the second shot he has the same thing after a month now. Right now, he can extend his arm out. It probably started right after he got the vaccine, but the sharp pain now is what bugs him. He can stand here now and extend his arm out and bend his elbow up and feel a little bit of pain, but nothing major. Every once in a while, it will turn into a sharp pain and he will move a certain way and have sharp pain. It has gotten worse over time. He thought it was something that would fade away over time. He can stand and move his arm every which direction, but he will be doing some work around the house and suddenly have a sharp pain. He can't duplicate the pain right now. The question he is posing is if this is something that is being reported and if it is a concern or not a concern. He realizes it is all new, and that is why he is posing the question. He asks if this is expected or out of the ordinary. The patient's lab test include blood work two weeks after the shot, but it was nothing for his arm. The clinical outcome of the event was reported as not recovered.  No follow-up attempts are possible.
Auto immune issues, Rheumatoid arthritis in hands, back, ankles, abnormal blood work.  Pain in hands and body
Sudden onset of vomiting, skin became cold and clammy, pallor, weakness, extreme lethargy. Pt parent brought back in. Examined by physician watched in office for 40 minutes. Awoke, but still overly drowsy. Parents given instructions to report any changes.
monovalent vaccine given as booster; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (monovalent vaccine given as booster) and NO ADVERSE EVENT (No adverse event) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (monovalent vaccine given as booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (monovalent vaccine given as booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (monovalent vaccine given as booster).    No concomitant medications were reported.  It was reported that the caller was the office manager. She had a situation. She found out that they could not give the Moderna as a booster starting 31-Aug-2022, but she administered 15 monovalent doses as boosters. She called public health, who said there was no harm in it. She was also told to call VAERS. She was told that the booster that they received did not cover omicron, so they would need to be revaccinated with the bivalent later.  No treatment medications were reported.
This spontaneous report as received from a consumer, as part of a marketing research program, and refers to his/her father of unknown age. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of pneumococcal vaccine (manufacturer unknown) (administration route, lot number and expiration date were not provided). No concomitant therapies were reported. The reporter stated that the patient died 3 months (also reported as 6 months) after being vaccinated from a stroke (cerebrovascular accident), for which the patient was hospitalized (dates not reported). The outcome of the cerebrovascular accident was reported as fatal. The cause of death was reported as cerebrovascular accident and it was unknown if an autopsy was performed. The relatedness between the cerebrovascular accident the Pneumococcal vaccine (manufacturer unknown) was not reported. Additional information is not expected, since the reporter did not want the company to contact the physician to discuss further.
thought that it might be a stroke; Lip is dripping at the right side; A spontaneous report was received from a Healthcare professional which concerns 37-year-old male nurse patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced a situation where his right lip is dripping and thought that it might be a stroke.  The patient's medical history was not provided. The concomitant medication included Tizanidine.  On 23-Dec-2021, approximately 27 days prior to the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 037K20A) intramuscularly for prophylaxis of COVID-19 infection.   On 18-Jan-2021, Patient experienced a situation where his right lip are is dripping and thought that it might be a stroke.  Treatment information was not provided.  Action taken with mrna-1273 in response to the events was unknown.  The outcome of the event(s) where his right lip is dripping and thought that it might be a stroke was unknown.; Reporter's Comments: Limited information regarding these events has been provided at this time.  Further information has been requested.
Itching at injection site since the vaccine. Got one dose on left arm and one in right arm and both are itchy everyday since the vaccine and sometimes have pain when lifting arms. Itching is exactly where the vaccine was administered. No rash or bump just itch.
some swelling in her arm at the injection site; sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (some swelling in her arm at the injection site) and VACCINATION SITE PAIN (sore at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included ATENOLOL and VITAMINS NOS for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE SWELLING (some swelling in her arm at the injection site) and VACCINATION SITE PAIN (sore at the injection site). On 15-Jan-2021, VACCINATION SITE SWELLING (some swelling in her arm at the injection site) and VACCINATION SITE PAIN (sore at the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported. On 15-Jan-2021, the soreness and swelling seemed to be easing a little bit.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt recv vax on 1/22/99; on 2/1/99 pt exp fever x 3 day (103), decreased appetite, bumpy rash on chest, face & stomach
THE EVENING AFTER BOTH INJECTIONS WERE GIVEN PATIENT DEVELOPED FEVER, CHILLS, AND SHAKING ALONG WITH LATHARGY AND IRRITABLILITY
Feeling cold; Body inflamed; COVID-19; COVID-19; Pain/Sore; FACILITATED COLLECT  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4255170-00.  A 59 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 22Aug2021 (Batch/Lot number: unknown) at the age of 59 years as dose 3 (booster), single, intramuscular, administration date 29Apr2021 (Batch/Lot number: unknown) as dose 2, single and intramuscular, administration date 01Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Lot number: 1154253) for rheumatoid arthritis. The patient's relevant medical history and concomitant medications were not reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 01Jan2022, outcome "recovering" and all described as "COVID-19"; PAIN (non-serious) with onset 01Jan2022, outcome "recovered" (07Jan2022), described as "Pain/Sore"; FEELING COLD (non-serious), outcome "unknown", described as "Feeling cold"; INFLAMMATION (non-serious), outcome "unknown", described as "Body inflamed". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (01Jan2022) positive. The action taken for adalimumab was dosage permanently withdrawn.   The reporter's causality for the events covid-19, feeling cold, pain, body inflamed with BNT162B2 was not reported. The reporter's causality for the event of felt cold and body inflamed with Humira was not provided. The reporter's causality for the event of covid-19 with Humira (adalimumab) was no reasonable possibility. The reporter's causality for the event of pain/sore with Humira (adalimumab) was a reasonable possibility.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events VACCINATION FAILURE, covid-19, PAIN, INFLAMMATION, and FEELING COLD and BNT162B2.
10 minutes post-vaccine, patient developed itchy rash on right cheek. Symptoms include itching, burning, tingling at rash site. Patient also felt thirsty (was then given water). Benadryl oral was given, but symptoms did not resolve and patient began to feel feverish and dizzy. Itch worsened and spread throughout body. Dexamethasone oral was given 15 minutes later. Itching started in mouth. EpiPen was administered intramuscularly to left vastus lateralis. Hypertension was noted post administration. Itching in  mouth subsided, but patient began to feel shaky and still felt dizzy. Monitored for additional 20 minutes. After, patient was stable, walked out via wheelchair enroute home.
Patient presented with a swollen arm. There was redness around the site of injection (approx. 1 1/2 - 2" in diameter). It was painful to the touch where vaccine was given and where there was redness. Patient states there is a knot if you press down hard enough at the site. Also painful if pt. lies down on that arm. It has been 3 days since injection. Advised pt. to take MOTRIN and BENADRYL and we will follow up with her.
12 hours after first shot, had 48 hours of chills and nausea, recovered, 8 days after first shot had 5 days of chills, fever, nausea, headache.  12 hours after second shot, had 24 hours of chills, nausea, fever, headache, recovered.  13 days after second shot, all symptoms returned for the 4th time
Itchy small bumps/rash on upper left arm near injection site 6 days (January 24th)  after first dose of vaccine. Also, 2 larger itchy bumps on right arm on Feb 3rd. Itchy bumps/rash on left elbow approximately 2 weeks (approximately March 5th) after 2nd dose of vaccine (which was taken on Feb 18 2021).